Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
pulmonary edema/otok
Веза се чува у привремену меморију
Страна 1 од 91 резултати
Systems and methods for monitoring pulmonary edema dynamics
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD
This document pertains generally to medical systems, devices, or methods, and more particularly, but not by way of limitation, to systems and methods for monitoring pulmonary edema.
BACKGROUND
One hallmark of heart failure (HF) in a subject is congestion, more commonly referred to as
Use of hyperpolymeric hemoglobin for the treatment of pulmonary edema
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
CROSS REFERENCE TO RELATED APPLICATIONS
Applicant claims priority under 35 U.S.C. .sctn.119 of German Application No. 103 52 692.7 filed Nov. 12, 2003. Applicant also claims priority under 35 U.S.C. .sctn.365 of PCT/EP2004/012363 filed Nov. 2, 2004. The international application under PCT article
Treatment of acute pulmonary edema with arginine esters
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention relates to novel therapeutic composition, particularly useful against acute pulmonary edema, shock caused by bacterial endotoxins, hyperfibrinolysis and anaphylactic shock. More specifically, the present invention relates to esters of L-arginine.
Many esters of L-arginine are
System and method for detecting heart failure and pulmonary edema based on ventricular end-diastolic pressure using an implantable medical device
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION
The invention generally relates to implantable medical devices, such as pacemakers or implantable cardioverter/defibrillators (ICDs), and in particular to techniques for measuring left ventricular end diastolic pressure (LV EDP) and for detecting the onset of heart failure and
Method and apparatus to monitor pulmonary edema
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD
The invention relates to medical devices, and more particularly, to medical devices that sense cardiac electrical signals.
BACKGROUND
Heart failure refers to the heart's inability to keep up with the demands made upon it. Congestive heart failure refers to an inability of the heart
Method and apparatus for detecting pulmonary edema
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD
This application relates generally to medical applications, and to detection of acute decompensation and pulmonary-related conditions.
BACKGROUND
The health of many patients who have had a heart attack may deteriorate over time due to progressive heart failure. For example, a heart
Enhancements to the detection of pulmonary edema when using transthoracic impedance
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
CROSS-REFERENCE TO RELATED APPLICATION
This patent application is related to U.S. patent application, entitled "IMPROVED SENSITIVITY AND SPECIFICITY OF PULMONARY EDEMA DETECTION WHEN USING TRANSTHORACIC IMPEDANCE," filed even date herewith Ser. No. 11/126,723 which is hereby incorporated by
Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
CROSS-REFERENCE TO RELATED APPLICATION
This patent application is related to U.S. Pat. Application Ser. No. 11/126,689, entitled "ENHANCEMENTS TO THE DETECTION OF PULMONARY EDEMA WHEN USING TRANSTHORACIC IMPEDANCE," filed May 11, 2005, which is hereby incorporated by reference in its
Enhancements to the detection of pulmonary edema when using transthoracic impedance
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD
This patent document pertains generally to medical systems, devices, and methods, and more particularly, but not by way of limitation, to medical systems, devices, and methods for the detection of pulmonary edema using thoracic impedance.
BACKGROUND
Variations in how much fluid is
Systems and methods for treating pulmonary edema
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD
The present disclosure relates generally to systems and methods for treating pulmonary edema.
BACKGROUND
The lymphatic system is part of the circulatory system in conjunction with the arterial and venous systems. A primary function of the lymphatic system is to drain excessive interstitial
Method and implantable medical device for assessing a degree of pulmonary edema of a patient
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to implantable medical devices, such as cardiac pacemakers and implantable cardioverter/defibrillators, and in particular to an improved method and an implantable medical device for assessing a degree of
System and method for identifying a potential cause of pulmonary edema
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
CROSS REFERENCE TO RELATED APPLICATIONS
This application is related to U.S. Pat. No. 7,676,260 Ser. No. 11/740,733, filed Apr. 26, 2007, titled "Implantable Cardiac Stimulation Device That Monitors Progression and Regression of Heart Disease Responsive to Differences in Averaged Electrograms and
Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
Methods and compositions are provided for gene therapy for pulmonary edema by the transfer of Na,K-ATPase subunit genes to lung epithelial cells for the purpose of increasing levels of Na, K-ATPase in vivo.
Cardiogenic and non-cardiogenic pulmonary edema affect millions
Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
INOmax.RTM., (nitric oxide) for inhalation is an approved drug product for the treatment of term and near-term (>34 weeks gestation) neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension.
The use of
Methods and systems that use implanted posture sensor to monitor pulmonary edema
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is related to the following commonly assigned U.S. Patent Applications, each of which is incorporated herein by references: U.S. patent application Ser. No. 11/863,516, entitled "Use of Cardiogenic Impedance Waveform Morphology to Analyze
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
